Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
Heyman Richard A. sold 6,700 Oric Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 1, 2026 · Filed Oct 2, 2026
On Oct 1, 2026, Heyman Richard A. (Director) sold 6,700 Oric Pharmaceuticals, Inc. shares at US$12.91 for US$86,524 under a trading plan, leaving 203,472 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 6,700 shares
- Price
- US$12.91
- Value
- US$86,524
- Holding after
- 203,472 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Option exercise | 3,500 | US$1.60 | 41,800 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 3,500 | US$12.91 | 38,300 | Direct |
| Oct 1, 2026 | Common Stock | Sale | 3,200 | US$12.91 | 203,472 | Indirect |
Source
Related
- Oric Pharmaceuticals, Inc.
- Heyman Richard A.
- Oric Pharmaceuticals, Inc. shareholders
- Form 4 · Heyman Richard A. · Jul 28, 2026
- Form 4 · Heyman Richard A. · Jul 8, 2026
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Sep 25, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026